JP2018534937A5 - - Google Patents

Download PDF

Info

Publication number
JP2018534937A5
JP2018534937A5 JP2018526799A JP2018526799A JP2018534937A5 JP 2018534937 A5 JP2018534937 A5 JP 2018534937A5 JP 2018526799 A JP2018526799 A JP 2018526799A JP 2018526799 A JP2018526799 A JP 2018526799A JP 2018534937 A5 JP2018534937 A5 JP 2018534937A5
Authority
JP
Japan
Prior art keywords
retrovirus
nucleic acid
vector
producing cell
retroviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018526799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018534937A (ja
JP7098521B2 (ja
Filing date
Publication date
Priority claimed from GBGB1520761.6A external-priority patent/GB201520761D0/en
Priority claimed from GBGB1609303.1A external-priority patent/GB201609303D0/en
Application filed filed Critical
Priority claimed from PCT/EP2016/078336 external-priority patent/WO2017089308A1/en
Publication of JP2018534937A publication Critical patent/JP2018534937A/ja
Publication of JP2018534937A5 publication Critical patent/JP2018534937A5/ja
Application granted granted Critical
Publication of JP7098521B2 publication Critical patent/JP7098521B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018526799A 2015-11-24 2016-11-21 レトロウイルス産生のための安定な細胞株 Expired - Fee Related JP7098521B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1520761.6 2015-11-24
GBGB1520761.6A GB201520761D0 (en) 2015-11-24 2015-11-24 Stable cell lines for retroviral production
GB1609303.1 2016-05-26
GBGB1609303.1A GB201609303D0 (en) 2016-05-26 2016-05-26 Stable cell lines for retroviral production
PCT/EP2016/078336 WO2017089308A1 (en) 2015-11-24 2016-11-21 Stable cell lines for retroviral production

Publications (3)

Publication Number Publication Date
JP2018534937A JP2018534937A (ja) 2018-11-29
JP2018534937A5 true JP2018534937A5 (enExample) 2020-01-09
JP7098521B2 JP7098521B2 (ja) 2022-07-11

Family

ID=57354376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018526799A Expired - Fee Related JP7098521B2 (ja) 2015-11-24 2016-11-21 レトロウイルス産生のための安定な細胞株

Country Status (17)

Country Link
US (3) US20170145388A1 (enExample)
EP (2) EP3380604B1 (enExample)
JP (1) JP7098521B2 (enExample)
KR (1) KR102091957B1 (enExample)
CN (1) CN108291208A (enExample)
AU (1) AU2016360763B2 (enExample)
BR (1) BR112018010635A2 (enExample)
CA (1) CA3006288A1 (enExample)
DE (1) DE102016122316A1 (enExample)
ES (2) ES2939617T3 (enExample)
FR (1) FR3044016A1 (enExample)
GB (1) GB2544892B (enExample)
IL (2) IL259254A (enExample)
IT (1) IT201600117326A1 (enExample)
RU (1) RU2752498C2 (enExample)
SA (1) SA518391623B1 (enExample)
WO (1) WO2017089308A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1970681A4 (en) * 2005-12-21 2011-01-19 Ishida Seisakusho ROTARY MEASURING DEVICE
BR112018010639A2 (pt) 2015-11-24 2019-01-22 Glaxosmithkline Ip Dev Ltd método de transfecção transitória para produção retroviral.
GB201706121D0 (en) 2017-04-18 2017-05-31 Glaxosmithkline Ip Dev Ltd Stable cell lines for retroviral production
GB201715052D0 (en) 2017-09-19 2017-11-01 Oxford Genetics Ltd Vectors
EP3696272A1 (en) 2017-12-22 2020-08-19 Oxford BioMedica (UK) Limited Retroviral vector
KR20210108406A (ko) * 2018-12-21 2021-09-02 론자 워커스빌 아이엔씨. 바이러스 벡터의 자동화된 생산
KR20220047635A (ko) 2019-08-23 2022-04-18 론자 워커스빌 아이엔씨. 렌티바이러스 벡터의 생산을 위한 방법 및 작제물
EP4077642A1 (en) 2019-12-18 2022-10-26 Lonza Walkersville, Inc. Methods and constructs for transient production of lentiviral vector
GB202004371D0 (en) 2020-03-26 2020-05-13 Glaxosmithkline Ip Dev Ltd CAR constructs
GB202005096D0 (en) 2020-04-07 2020-05-20 Glaxosmithkline Modified vectors for production of retrovirus
CN113528515B (zh) * 2020-04-22 2023-05-05 中国科学院分子植物科学卓越创新中心 基于CRISPR-Cas13a干预阻断病毒逆转录转座的技术
CA3183599A1 (en) * 2020-05-15 2021-11-18 Ivexsol, Inc. Compositions and methods for producing stable viral vector producer cells for cell and gene therapy
CN112430582B (zh) * 2020-12-04 2022-05-03 北京艺妙神州医药科技有限公司 一种慢病毒稳定包装细胞系及其制备方法
CN118638226A (zh) 2021-03-19 2024-09-13 葛兰素史密斯克莱知识产权发展有限公司 靶向密蛋白3的嵌合抗原受体和治疗癌症的方法
WO2022225973A1 (en) * 2021-04-20 2022-10-27 The Regents Of The University Of California Packaging cells with targeted gene knockouts that improve retroviral vector titers
WO2024149284A1 (en) * 2023-01-10 2024-07-18 Nanjing Legend Biotech Co., Ltd. Regulatory sequences and uses thereof
EP4698215A1 (en) 2023-04-19 2026-02-25 GlaxoSmithKline Intellectual Property Development Limited Cytotoxicity targeting chimeras for car-t and car-nk cells
WO2024218345A1 (en) 2023-04-21 2024-10-24 Glaxosmithkline Intellectual Property Development Limited Cytotoxicity targeting chimeras for antibody-drug conjugates and bispecific antibodies
CN116804211A (zh) * 2023-05-09 2023-09-26 浙江大学 促进猪病毒复制的malt1稳转细胞系及其构建方法
WO2026032970A1 (en) 2024-08-07 2026-02-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Cd4-specific chimeric antigen receptor and methods and uses thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
WO1995003400A1 (en) * 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
CN1187095C (zh) * 1995-06-27 2005-02-02 巴法里安诺迪克有限公司 可生产病毒颗粒的被囊化细胞
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
EP1179083A4 (en) * 1999-04-22 2003-04-23 Gen Hospital Corp TRIPLE HYBRID AMPLICON VECTOR SYSTEMS FOR THE PRODUCTION OF RETROVIRUS PACKING CELL LINES
US6677155B1 (en) * 1999-04-22 2004-01-13 The General Hospital Corporation Triple hybrid amplicon vector systems to generate retroviral packaging lines
CA2371946A1 (en) * 1999-04-29 2000-11-09 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
AU2001265187A1 (en) * 2000-05-30 2001-12-11 Baylor College Of Medicine Chimeric viral vectors for gene therapy
US6689601B2 (en) * 2000-09-01 2004-02-10 E. I. Du Pont De Nemours And Company High growth methanotropic bacterial strain
US6586251B2 (en) * 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
DE10111433A1 (de) * 2001-03-09 2002-09-19 Bundesrepublik Deutschland Let Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen
CA2441937A1 (en) 2001-05-30 2002-12-05 Chromos Molecular Systems, Inc. Chromosome-based platforms
US6835568B2 (en) * 2001-10-30 2004-12-28 Virxsys Corporation Regulated nucleic acid expression system
DK1504108T3 (da) * 2002-02-01 2013-06-10 Oxford Biomedica Ltd Lentivirusvektor
AU2003293675B2 (en) * 2002-11-25 2009-04-23 Bavarian Nordic A/S Recombinant poxvirus comprising at least two cowpox ATI promoters
EP1743028A2 (en) * 2004-04-28 2007-01-17 The Trustees Of The University Of Pennsylvania Polyvalent viral vectors and a system for production thereof
EP1652932A1 (en) * 2004-11-02 2006-05-03 GBF Gesellschaft für Biotechnologische Forschung mbH Method for the generation of virus producing cell lines and cell lines
ATE495246T1 (de) * 2004-11-24 2011-01-15 Anaeropharma Science Inc Neuartiger shuttle-vektor
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
WO2010131747A1 (ja) * 2009-05-15 2010-11-18 国立大学法人 東京大学 ウイルス産生細胞
KR101990068B1 (ko) * 2010-09-02 2019-06-17 몰메드 에스피에이 렌티바이러스 벡터의 안정한 제조
US9273324B2 (en) * 2010-12-05 2016-03-01 Andrew S. Belmont Recombinant gene expression
WO2012170431A2 (en) * 2011-06-06 2012-12-13 Bluebird Bio, Inc. Improved geneswitch systems
FR2979919B1 (fr) * 2011-09-12 2015-12-11 Centre Nat Rech Scient Genomes lentiviraux chimeriques non-integratifs comme vaccins innovants contre vih-1
GB201202516D0 (en) * 2012-02-13 2012-03-28 Ucl Business Plc Materials and methods relating to packaging cell lines
JP2015529466A (ja) * 2012-09-14 2015-10-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター
US11065311B2 (en) * 2012-10-25 2021-07-20 Denovo Biopharma Llc Retroviral vector with mini-promoter cassette
US11078464B2 (en) * 2013-08-30 2021-08-03 Amgen Inc. High titer recombinant AAV vector production in adherent and suspension cells
GB2538324A (en) * 2015-05-15 2016-11-16 Glaxosmithkline Ip Dev Ltd Packaging cell line for retroviral production
GB2538321A (en) * 2015-05-15 2016-11-16 Glaxosmithkline Ip Dev Ltd Artificial chromosome for retroviral production
DK3351851T3 (da) * 2015-09-01 2020-01-06 Signify Holding Bv Belysningsindretning med en trådløs kommunikationsantenne
BR112018010639A2 (pt) * 2015-11-24 2019-01-22 Glaxosmithkline Ip Dev Ltd método de transfecção transitória para produção retroviral.

Similar Documents

Publication Publication Date Title
JP2019500030A5 (enExample)
RU2018122636A (ru) Стабильные клеточные линии для продуцирования ретровирусов
CA3076270C (en) Retroviral vectors
RU2018118964A (ru) Способ временной трансфекции для продуцирования ретровируса
JP5749014B2 (ja) ポリプリントラクト改変レトロウイルスベクター
JP7672114B2 (ja) 安定したレンチウイルスパッケージング細胞株およびその作成方法
CA3120282A1 (en) Fusosome compositions for hematopoietic stem cell delivery
BR112020023015A2 (pt) composições de fusossoma e usos das mesmas
JP2018530336A5 (enExample)
JP6975643B2 (ja) レンチウイルスベクターのバイオ生産法
CA2456169A1 (en) Methods and compositions relating to improved lentiviral vector production systems
JP2023513303A (ja) レンチウイルスベクターの製造
JP2023504593A (ja) 産生系
JP6878620B2 (ja) レトロウイルス産生のための安定な細胞株
US20180127470A1 (en) Cell Lines
JP2023539700A (ja) 哺乳動物細胞及びその改変方法
JP2025507849A (ja) 昆虫細胞及びその改変方法
CN114277030A (zh) 一种pri-miRNA改良序列及表达该序列的载体
RU2013115637A (ru) Усовершенствование генетических конструкций для повышения эффективности антивич терапии
Zhang et al. Reverse Genetics-Based Methodology for Molecular Virology Study
JP6775728B2 (ja) 遺伝子組換型細胞、並びにワクチン製造方法
AU2019269593B2 (en) Fusosome compositions and uses thereof
RU2670128C2 (ru) Способ генетической регистрации и коррекции нейрогенеза на основе генетических конструкций для трансфекции нейронов
US20230151388A1 (en) Modified vectors for production of retrovirus
JP2026081307A (ja) フソソーム組成物およびその使用